Trials / Completed
CompletedNCT01205477
Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment
Phase 2 Double-blinded, Placebo-controlled, Clinical Trial for Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Universidad Autonoma de Nuevo Leon · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the safety and efficacy of methylprednisolone infiltration in anserine bursitis treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EXPERIMENTAL | Infiltration of 40 mg of methylprednisolone acetate plus 1 mL of xylocaine and Diclofenac sodium 100 mg PO QD for 10 days |
| DRUG | PLACEBO | Infiltration of 1 mL of xylocaine and Diclofenac sodium 100 mg PO QD for 10 days |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2010-09-20
- Last updated
- 2010-09-20
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01205477. Inclusion in this directory is not an endorsement.